首页> 外文OA文献 >Results of a Randomized, Open Label, Multicenter Trial Assessing the Safety, Dose and Schedule of RRx-001 (R001) in Reducing Severe Oral Mucositis (SOM) in Patients Receiving Chemoradiation (CRT) for Oral Cavity/oropharynx Squamous Cell Carcinoma (OSCC)

【2h】

Results of a Randomized, Open Label, Multicenter Trial Assessing the Safety, Dose and Schedule of RRx-001 (R001) in Reducing Severe Oral Mucositis (SOM) in Patients Receiving Chemoradiation (CRT) for Oral Cavity/oropharynx Squamous Cell Carcinoma (OSCC)

机译：随机开放标签，多中心试验评估RRX-001（R001）的安全性，剂量和时间表减少严重口腔粘膜炎（SOM），用于接受口腔口腔鳞癌（CRT）的患者中的患者/ oropharynx鳞状细胞癌（OSCC）

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
相似文献
相关主题

著录项

作者
D.J. Sher; M. Bonomi; D.M. Blakaj; R. Kabarriti; K.T. Colvett; B. Oronsky; S. Caroen; S.T. Sonis; J.A. Bianco;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. A Randomized, Placebo (PBO) Controlled, Double-Blind P2b Trial of GC4419 (Avisopasem Manganese) to Reduce Severe Radiation-Related Oral Mucositis (SOM) in Patients (pts) with Locally Advanced Squamous Cell Cancer of the Oral Cavity (OC) or Oropharynx (OP) [J] . Anderson C. M., Lee C., Saunders D., International Journal of Radiation Oncology, Biology, Physics . 2018,第3Suppla期

机译：随机的安慰剂（PBO）控制，GC4419（Avisopasem锰）的双盲P2B试验，以减少患者（PTS）中的严重辐射相关的口腔粘膜炎（SOM），具有口腔（OC）的局部晚期鳞状细胞癌 oropharynx（op）
2. Phase 1b/2a Trial of Superoxide (SO) Dismutase (SOD) Mimetic GC4419 to Reduce Chemoradiation Therapy-Induced Oral Mucositis (OM) in Patients With Oral Cavity or Oropharyngeal Carcinoma (OCC) [J] . Anderson C. M., Allen B. G., Sun W., International Journal of Radiation Oncology, Biology, Physics . 2016,第4期

机译：超氧化物歧化酶（SOD）模拟GC4419的1b / 2a期临床试验可减少口腔或口咽癌（OCC）患者的化学放疗诱导的口腔粘膜炎（OM）
3. A Randomized Controlled Trial to Evaluate the Role and Efficacy of Oral Glutamine in the Treatment of Chemo-radiotherapy-induced Oral Mucositis and Dysphagia in Patients with Oropharynx and Larynx Carcinoma [J] . Shuchita Pathak, Tej P. Soni, Lalit M. Sharma, Cureus. . 2019,第6期

机译：评价口服谷氨酰胺在口咽喉癌患者放化疗引起的口腔黏膜炎和吞咽困难中的作用和疗效的随机对照试验
4. Hpv prevalence in squamous cell carcinomas of the oral cavity and oropharynx as markers of biological behaviours [C] . Silini Enrico M., Lombardi Mariano, Corcione Luigi Societaà Italiana Chirurgia Maxillo-Facciale . 2011

机译：口腔鳞状细胞癌的HPV流行和oropharynx作为生物行为标记
5. Addendum: Perri et al. Electrochemotherapy as a First Line Treatment in Recurrent Squamous Cell Carcinoma of the Oral Cavity and Oropharynx PDL-1 Negative and/or with Evident Contraindication to Immunotherapy: A Randomized Multicenter Controlled Trial. Cancers 2021 13 2210 [O] . Francesco Perri, Francesco Longo, Roberta Fusco, 2021

机译：附录：Perri等。电化学疗法作为口腔复发鳞状细胞癌的第一线治疗口腔鳞状细胞癌和/或具有明显的免疫疗法的阴性和/或明显的禁忌症：随机化多元对照试验。癌症2021132210
6. A Randomized, Placebo (PBO) Controlled, Double-Blind P2b Trial of GC4419 (Avisopasem Manganese) to Reduce Severe Radiation-Related Oral Mucositis (SOM) in Patients (pts) with Locally Advanced Squamous Cell Cancer of the Oral Cavity (OC) or Oropharynx (OP) [O] . C.M. Anderson, C. Lee, D. Saunders, 2018

机译：随机的安慰剂（PBO）控制，GC4419（Avisopasem锰）的双盲P2B试验，以减少患者（PTS）中的严重辐射相关的口腔粘膜炎（SOM），具有口腔（OC）的局部晚期鳞状细胞癌oropharynx（op）

Results of a Randomized, Open Label, Multicenter Trial Assessing the Safety, Dose and Schedule of RRx-001 (R001) in Reducing Severe Oral Mucositis (SOM) in Patients Receiving Chemoradiation (CRT) for Oral Cavity/oropharynx Squamous Cell Carcinoma (OSCC)

著录项

相似文献

相关主题

期刊订阅